| Row | Study Title | Conditions | Interventions | Detail |
|---|---|---|---|---|
| 312 | Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years | Influenza|Pneumonia|Lower Respiratory Tract Infection|Acute Myocardial Infarction|Congestive Heart Failure|Stroke |
Biological:Flublok Quadrivalent Biological:Standard Dose Inactivated Influenza Vaccine (SD-IIV) |
detail |
| 313 | Apneic Oxygenation Including Precipitous Intubations During RSI in the ED | Apneic Oxygenation|Endotracheal Intubation |
Other:Apneic oxygenation during endotracheal intubation |
detail |
| 314 | Integrated Community Based Health Systems Strengthening in Northern Togo | Maternal and Child Health|Health Service Utilization |
Other:ICBHSS model |
detail |
| 315 | Study to Evaluate the Safety and Efficacy of Self Administered Injections of Pegvaliase (>40mg/Day Dose) in Adults With PKU | Phenylketonuria (PKU) |
Drug:pegvaliase |
detail |
| 316 | Optimization of Cochlear Implant MAP-parameters in Children | Cochlear Implants|Evoked Potentials, Auditory|Child|Disabilities Hearing|Deafness|Hearing |
Other:Re-programming of cochlear implant |
detail |
| 317 | Innovative Digital Therapeutic for Smoking Cessation | Smoking Cessation|Nicotine Addiction|Drug Addiction|Drug Dependence|Tobacco Dependence|Tobacco Use Disorder|Substance Use Disorder|Tobacco Smoking |
Device:Treatment A Digital Intervention Device:Treatment B Digital Intervention |
detail |
| 318 | Effect of Omega-3 Fatty Acids on Sleep and Behavior (Pilot Study) | Disturbances in Initiating and Maintaining Sleep|Behavior Problem |
Dietary Supplement:Omega-3 fatty acids Dietary Supplement:Placebo |
detail |
| 319 | Physiological Data Analysis of Patients Undergoing Anesthesia for Liver Transplantation | Liver Transplantation |
: |
detail |
| 320 | The FIRM Trial - A Randomized Clinical Trial Evaluating Fixation In-situ vs Removal for Midfoot Lisfranc Injuries | Lisfranc Injuries |
Procedure:Implant removal |
detail |
| 321 | A Multicenter, Open-label, Pilot Study of TAK-935 (OV935) in Participants With 15Q Duplication Syndrome or CDKL5 Deficiency Disorder | 15q Duplication Syndrome|CDKL5 Deficiency Disease |
Drug:TAK-935 |
detail |
京公网安备 11010102003638号